Bone Marrow TransplantationTransplantation, AutologousBone MarrowAntineoplastic Combined Chemotherapy ProtocolsBone Marrow CellsPeripheral Blood Stem Cell TransplantationCombined Modality TherapyTransplantation, HomologousHematopoietic Stem Cell TransplantationCyclophosphamideTreatment OutcomeGraft vs Host DiseaseAntineoplastic AgentsChemotherapy, AdjuvantWhole-Body IrradiationBone and BonesLymphoma, Non-HodgkinAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraBone Marrow PurgingLiver TransplantationBone Marrow DiseasesHematopoietic Stem CellsGraft SurvivalBusulfanTissue DonorsSalvage TherapyHistocompatibility TestingHistocompatibilityBone Marrow ExaminationRecurrenceHematopoiesisTime FactorsSurvival AnalysisTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone Marrow NeoplasmsMice, Inbred C57BLDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationRadiation ChimeraEtoposideSurvival RateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidHematologic NeoplasmsImmunosuppressive AgentsDose-Response Relationship, DrugPrognosisDoxorubicinRemission InductionGraft RejectionHepatic Veno-Occlusive DiseaseColony-Forming Units AssayAcute DiseaseStem Cell TransplantationCytarabineCisplatinFollow-Up StudiesBone RemodelingMethotrexateGraft vs Host ReactionImmunosuppressionCarmustineTransplantation ImmunologyLymphocyte DepletionGranulocyte Colony-Stimulating FactorMyelodysplastic SyndromesHematologic DiseasesActuarial AnalysisLeukocyte TransfusionT-LymphocytesMelphalanHeart TransplantationDrug Administration ScheduleChimeraSevere Combined ImmunodeficiencyHodgkin DiseaseHLA AntigensLeukocyte CountLymphomaRetrospective StudiesCell DifferentiationMultiple MyelomaCyclosporinePancytopeniaFlow CytometryLymphocyte TransfusionMice, Inbred BALB CSpleenBone NeoplasmsBone DensityLung TransplantationAntibodies, MonoclonalBreast NeoplasmsProspective StudiesCells, Cultured